A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–58
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participant must be 18 to 58 years of age inclusive, at the time of signing the informed consent.
Participants who are overtly healthy as determined by medical evaluation including medical history, physical examination, vital signs (blood pressure and heart rate), electrocardiogram (ECG), body temperature, and laboratory tests.
Body Mass Index (BMI) within the range 18.0 and 29.9 kg/m\^2 (inclusive).
Body weight above or equal 60 kg.
Male and female.
You may not be if
Pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination, and effects of the study interventions will not be normal.
Acute diarrhea or constipation within 14 days before the first intake of study intervention.
Regular use of medicines within the last 14 days before the first study intervention administration.
Special diets preventing the participants from eating the standard meals during the study.
Participant is unable or unwilling to comply with study restrictions.
Clareo Health | A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body
